Finasteride in the Treatment of Female Androgenic Alopecia

The document reviewed the effectiveness of Finasteride, a medication primarily used for male pattern hair loss, in treating Female Androgenic Alopecia (FAGA). Studies included in the review involved postmenopausal and premenopausal women, with varying androgen levels, and used dosages of 1 mg/day to 5 mg/day over periods ranging from several months to two years. Results were mixed, with some studies showing improvements in hair counts and density, while others found no significant difference from placebo. Side effects were minimal but included reduced libido and elevated liver enzymes in some cases. The review concluded that while Finasteride shows promise for treating FAGA in postmenopausal women, its effectiveness is not universal, and caution is advised when considering its use in premenopausal women due to potential teratogenic effects. Further research is needed to establish the optimal dosing and patient population.